{
    "organizations": [],
    "uuid": "ef1d582a0c803dfe01f0fa2b533db63e76ad5623",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-foundation-medicine-enters-into-am/brief-foundation-medicine-enters-into-amended-and-restated-ex-us-commercialization-agreement-with-f-hoffmann-la-roche-ltd-idUSFWN1QN0R1",
    "ord_in_thread": 0,
    "title": "BRIEF-Foundation Medicine Enters Into Amended And Restated Ex-US Commercialization Agreement With F. Hoffmann-La Roche Ltd",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Foundation Medicine Inc:\n* FOUNDATION MEDICINE SAYS ON FEB 28, CO ENTERED INTO AMENDED AND RESTATED EX-US COMMERCIALIZATION AGREEMENT WITH F. HOFFMANN-LA ROCHE LTD - SEC FILING\n* FOUNDATION MEDICINE INC - AGREEMENT AMENDS AND RESTATES THAT CERTAIN EX-US COMMERCIALIZATION AGREEMENT, EFFECTIVE AS OF APRIL 7, 2015\n* FOUNDATION MEDICINE- PER AGREEMENT, ROCHE HAS EXCLUSIVE RIGHT IN TERRITORY TO COMMERCIALIZE COâ€™S CLINICAL DIAGNOSTIC TESTING COMMERCIAL PRODUCTS\n* FOUNDATION MEDICINE INC - INITIAL TERM OF AGREEMENT EXPIRES ON APRIL 7, 2020 AND MAY BE EXTENDED BY ROCHE FOR ADDITIONAL TWO-YEAR PERIODS Source text ( bit.ly/2FiMt07 ) Further company coverage:\n ",
    "published": "2018-03-06T05:47:00.000+02:00",
    "crawled": "2018-03-06T22:29:01.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "foundation",
        "medicine",
        "inc",
        "foundation",
        "medicine",
        "say",
        "feb",
        "co",
        "entered",
        "amended",
        "restated",
        "commercialization",
        "agreement",
        "roche",
        "ltd",
        "sec",
        "filing",
        "foundation",
        "medicine",
        "inc",
        "agreement",
        "amends",
        "restates",
        "certain",
        "commercialization",
        "agreement",
        "effective",
        "april",
        "foundation",
        "per",
        "agreement",
        "roche",
        "exclusive",
        "right",
        "territory",
        "commercialize",
        "co",
        "clinical",
        "diagnostic",
        "testing",
        "commercial",
        "product",
        "foundation",
        "medicine",
        "inc",
        "initial",
        "term",
        "agreement",
        "expires",
        "april",
        "may",
        "extended",
        "roche",
        "additional",
        "period",
        "source",
        "text",
        "company",
        "coverage"
    ]
}